Abstract
Nowadays there is a tendency towards the spread of viral diseases that cause significant complications to human health. Therefore, the question of creating new drugs that have a high antiviral effect is topical. The aim. To study the range of drugs in Ukraine for the treatment of herpes viral diseases. Materials and methods. In the work were used the list of drugs from official sources of information, which were processed by methods of generalization, systematization, graphic, comparative and structural analysis. Results and discussion. The marketing research of drugs for the treatment of herpes viral diseases presented at the pharmaceutical market of Ukraine has been conducted. According to the results it is found that 80 drugs for the treatment of herpes viral diseases of various dosage forms are presented in the domestic market, of which 70 % – tablets; 51 % – medicines produced by the industry of Ukraine; 94 % – are monocomponent preparations. Soft drugs play important role in the treatment of skin diseases because they provide a direct effect of the drugs on the pathogens, eliminate inflammatory phenomena and eliminate or reduce the symptoms of the disease. Soft dosage drugs have practically no contraindications, they can be used at any age, regardless of the presence of comorbidities. Conclusions. Domestic drugs (51 % of the total range) dominate in the market structure. The main part (94 %) consist of monocomponent preparations. The results of the research prove the relevance of the development of new combined soft dosage forms for the treatment of herpes viral diseases, which should be produced by the Ukrainian industry and satisfy the medical and economical needs of patients. The results of the marketing analysis show that it is relevant and promising to create new combined the soft dosage forms for the treatment of herpes viral diseases.
Highlights
Herpes viral diseases are among the most common diseases in the world, which is a leading medical and social problem [1, 2]
The results of the research prove the relevance of the development of new combined soft dosage forms for the treatment of herpes viral diseases, which should be produced by the Ukrainian industry and satisfy the medical and economical needs of patients
Materials and methods The subjects of the study were selected registered drugs at the pharmaceutical market of Ukraine which use in the pharmacotherapy of herpes viral diseases
Summary
Herpes viral diseases are among the most common diseases in the world, which is a leading medical and social problem [1, 2]. According to the WHO studies, about 80–90 % of the world’s population are infected with one or more types of herpes virus [3, 4]. In Europe, the third of the population is suffering from herpes viral diseases [7, 8]. Due to the immunosuppressive effect of herpes viruses, the immune system is impaired, which gradually leads to chronic infection and possible damage to various organs and systems (eyes, liver, mucous membranes, skin, CNS), as well as the ability to replicate in all “host” cells (leukocytes, monocytes, fibroblasts) [9, 10]. Viruses are capable of triggering apoptosis – a genetic program of cell death that contributes to the development of diseases of the internal organs [11]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
